Discover 395 paid clinical trials in Rochester, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Rochester has a wide variety of active clinical trials, focusing on conditions such as kidney disease, cancer, and cardiovascular disorders. Participants in these studies have the opportunity to explore emerging treatments in the city’s leading research institutions, both as healthy volunteers in paid trials and as individuals looking for studies targeting specific health conditions.
Filter
2
Filter results
Results: 395
Active & Responsive
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
for
Ovarian Cancer
Location: Rochester NY, Morristown NJ, Providence RI, Des Moines IA,
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 50 - 70+
Code: NCT00539162
Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Rochester NY, Toronto, London, Mentor OH, New York NY,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase2, Recruiting
Active & Responsive
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
for
Charcot Marie Tooth Disease
Location: Rochester NY, Philadelphia PA, Hartford CT, Ann Arbor MI,
Sponsor: University of Iowa
Sex: All
Age: 0 - 21
Code: NCT01203085
Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Rochester NY, Pittsburgh PA, Horsham PA, Philadelphia PA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase2, Recruiting
Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis